Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
peripheral artery disease
Marketing
J&J campaign brings PAD amputation awareness to Black community
Johnson & Johnson’s pharma unit Janssen is driving awareness among Black Americans of the risks for PAD-related amputations in a new campaign.
Jacqueline Renfrow
Nov 14, 2022 8:05am
J&J launches 'save legs' campaign for peripheral artery disease
Apr 11, 2022 8:32am
Abbott's research finds 'we all need to do better' for patients
Dec 15, 2021 7:45am
J&J's Xarelto charts long-term win in post-surgery PAD patients
May 16, 2021 8:00am
ACC: J&J, Bayer's Xarelto scores trial win in artery disease
Mar 28, 2020 10:00am
AZ has dumped billions into Brilinta, but will it ever pay off?
Jan 29, 2020 12:16pm